PT  - JOURNAL ARTICLE
AU  - Sophia Tan
AU  - Hailey Park
AU  - Isabel Rodríguez-Barraquer
AU  - George W. Rutherford
AU  - Kirsten Bibbins-Domingo
AU  - Nathan C. Lo
TI  - Estimation of COVID-19 cases prevented by vaccination in California
AID  - 10.1101/2022.02.08.22269319
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.08.22269319
4099  - http://medrxiv.org/content/early/2022/02/14/2022.02.08.22269319.short
4100  - http://medrxiv.org/content/early/2022/02/14/2022.02.08.22269319.full
AB  - Importance Despite widespread vaccination against COVID-19 in the United States, there are limited empirical data quantifying the public health impact in the population.Objective To estimate the number of cases of COVID-19 averted due to COVID-19 vaccinationDesign, Setting, and Participants The California Department of Public Health (CDPH) provided person-level data on COVID-19 cases and COVID-19 vaccine administration. To estimate the number of COVID-19 cases that would have occurred in the vaccine era in absence of vaccination, we applied a statistical model that estimated the relationship of COVID-19 cases in the pre-vaccine era between the unvaccinated age group (<12 years) and vaccine-eligible groups (≥12 years) to COVID-19 case data after the start of vaccination. The primary study outcome was the difference between predicted number of COVID-19 cases in absence of vaccination and observed COVID-19 cases with vaccination. As a sensitivity analysis, we developed a second independent model that estimated the number of vaccine-averted COVID-19 cases by applying published data on vaccine effectiveness to data on COVID-19 vaccine administration and estimated risk of COVID-19 over time.Intervention COVID-19 vaccinationMain Outcomes and Measures COVID-19 casesResults There were 4,585,248 confirmed COVID-19 cases in California from January 1, 2020 to October 16, 2021, during which 27,164,680 vaccine-eligible individuals ≥12 years were reported to have received at least 1 dose of a COVID-19 vaccine in the vaccine era (79.5% of the eligible population). We estimated that 1,523,500 [95% prediction interval (976,800-2,230,800)] COVID-19 cases were averted and there was a 34% [95% prediction interval (25-43)] reduction in cases due to vaccination in the primary model. Approximately 66% of total cases averted occurred after the delta variant became the dominant strain of SARS-CoV-2 circulating in California. Our alternative model identified comparable findings.Conclusions and Relevance This study provides robust evidence on the public health impact of COVID-19 vaccination in the United States and further supports the urgency for continued vaccination.Question How many COVID-19 cases have been prevented by COVID-19 vaccination in California?Findings In this empirical analysis of California using data from the Department of Public Health, we estimated that COVID-19 vaccination has prevented over 1.5 million COVID-19 cases from the introduction of vaccination through October 16, 2021.Meaning These findings support that COVID-19 vaccination had a large public health impact in California in terms of averted cases of COVID-19 and can be generalized across the United States.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the California Department of Public Health. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. This work represents the viewpoints of the authors alone and not necessarily those of the California Department of Public Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional review board at the University of California, San Francisco.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData on COVID-19 vaccination is publicly available online, and data on COVID-19 cases is available on request to CDPH. Analytic code is available online. https://github.com/sophttan/ca-vaccine-impact https://data.chhs.ca.gov/dataset/vaccine-progress-dashboard/resource/faee36da-bd8c-40f7-96d4-d8f283a12b0a